Nondefinitive PCa Treatment Linked With Race, Insurance Status
A study of patients aged 70 or younger with high-risk prostate cancer found that black and Hispanic race was associated with a greater likelihood of receiving nondefinitive treatment, with patients experiencing poor outcomes as a result.